(Q36283753)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16218893%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Azithromycin and lower respiratory tract infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16218893%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16218893%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Roberto Cosentini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16218893%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Stefano Aliberti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16218893%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Pierachille Santus

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16218893%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

M Cazzola

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16218893%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

P Tarsia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16218893%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

L Allegra

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16218893%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

1 October 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16218893%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Pharmacotherapy

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16218893%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16218893%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16218893%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

2335-2351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16218893%20AND%20SRC:MED&resulttype=core&format=json

The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Azithromycin for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Guidelines for severe community-acquired pneumonia in the western world

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Intracellular accumulation of azithromycin by cultured human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Characterization of azithromycin hydrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

The effect of azithromycin on intracellular Legionella pneumophila in the Mono Mac 6 cell line at serum concentrations attainable in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Pharmacokinetics of Oral Azithromycin in Serum, Urine, Polymorphonuclear Leucocytes and Inflammatory vs Non-Inflammatory Skin Blisters in Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Macrolide resistance among invasive Streptococcus pneumoniae isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Meta-analysis of bacterial resistance to macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Comparative study of azithromycin and amoxicillin/clavulanic acid in the treatment of lower respiratory tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Efficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Azithromycin versus comparative therapy for the treatment of community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Association between initial empirical therapy and decreased length of stay among veteran patients hospitalized with community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Safety and tolerability of azithromycin in pediatric infectious diseases: 2003 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Severe pneumonia and a second antibiotic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Macrolides for the treatment of Pseudomonas aeruginosa infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Bacterial biofilms: a common cause of persistent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Potential role of macrolide antibiotics in the management of cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Macrolide and occult infection in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Tissue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Tolerability of 3-day, once-daily azithromycin suspension versus standard treatments for community-acquired paediatric infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Antibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3,043 patients with acute exacerbation of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Effect of Macrolides as Part of Initial Empiric Therapy on Length of Stay in Patients Hospitalized With Community-Acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐Resistant Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2335

10.1517/14656566.6.13.2335

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16218893%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference